South Wales, July 10 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "POINT LUMINA" on June 26. The details about the trademark application no. UK00004408039 published in the journal no. 2026/028 (July 10).
With Harper James Ltd as representative, Point Lumina Medical Advisory Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 35 : Business management and business organisation consultancy; business strategy consultancy; advisory services relating to organisational design, operating models, capability development and resource planning within pharmaceutical, biotechnology and healthcare organisations; business consultancy relating to the management, structure and operation of medical affairs functions; advisory services relating to product launch planning, lifecycle management and market engagement strategies for pharmaceutical, biotechnology and healthcare products; business consultancy relating to evidence strategy, real world evidence integration and data dissemination strategies within life sciences organisations.
Class 41 : Education; providing of training; arranging and conducting conferences, seminars and workshops; provision of professional training and educational programmes for professionals working in the pharmaceutical, biotechnology and healthcare sectors; provision of educational courses and masterclasses relating to medical affairs, evidence generation and healthcare strategy; publication of educational and training materials in electronic form; coaching and professional development services for professionals working in medical affairs and healthcare organisations.
Class 42 : Scientific consultancy; medical and scientific research consultancy; consultancy and advisory services relating to medical affairs strategy and evidence generation within the pharmaceutical, biotechnology and healthcare sectors; advisory services relating to the planning, generation, analysis and dissemination of medical and scientific evidence; consultancy relating to healthcare innovation, real world evidence and data driven decision making in healthcare and life sciences organisations; providing information and advisory services relating to the use of digital technologies and data analysis in medical affairs and healthcare research.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004408039
Disclaimer: Curated by HT Syndication.
